Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Practice

Melatonin

Michael D. Carter and David N. Juurlink
CMAJ November 20, 2012 184 (17) 1923; DOI: https://doi.org/10.1503/cmaj.111765
Michael D. Carter
From the Class of 2012, Department of Medicine (Carter), University of Toronto, Toronto, Ont.; and the Departments of General Internal Medicine and of Clinical Pharmacology and Toxicology (Juurlink), Sunnybrook Health Sciences Centre, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: md.carter@utoronto.ca
David N. Juurlink
From the Class of 2012, Department of Medicine (Carter), University of Toronto, Toronto, Ont.; and the Departments of General Internal Medicine and of Clinical Pharmacology and Toxicology (Juurlink), Sunnybrook Health Sciences Centre, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading
Submit a Response to This Article
Compose Response

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
References
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Minimum 7 characters.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'. Minimum 12 characters.
Your organization, institution's or residential address.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

  • A few more things to know about melatonin
    Harold A. Pupko
    Posted on: 28 November 2012
  • Posted on: (28 November 2012)
    A few more things to know about melatonin
    • Harold A. Pupko, M.D.

    While the authors are limited by the one page format of the article, I see a danger in oversimplifying readers' understanding of this all too readily available drug, especially since the article does not address what happens when patients go beyond recommended doses. Two cases from the recent past to illustrate:

    Patient one suffered from chronic insomnia, and in desperation, took large amounts of melatonin, thinking...

    Show More

    While the authors are limited by the one page format of the article, I see a danger in oversimplifying readers' understanding of this all too readily available drug, especially since the article does not address what happens when patients go beyond recommended doses. Two cases from the recent past to illustrate:

    Patient one suffered from chronic insomnia, and in desperation, took large amounts of melatonin, thinking that if one pill was not enough to get her to sleep, then more would be better. When her menstrual cycles became disrupted, she ended up being over-investigated for menstrual irregularities. Having seen her after these investigations had begun, I pointed out to her that there was a time when melatonin was considered as a potential candidate for human contraception(1). When she discontinued the melatonin, her cycles were restored to baseline.

    Patient two was using melatonin based on reports in the medical literature of its potential benefit for the treatment of cancer(2) . While aiming for a daily dose of 20 mg, he could only tolerate 9 mg before having to discontinue due to severe constipation. Multiple attempts at reinstating the regimen ended due to constipation, and the problem resolved each time the melatonin was discontinued. Eventually this therapeutic path was abandoned. I had never heard of melatonin causing constipation, and in reviewing the literature, I was made aware of close to four decades worth of research on gastrointestinal melatonin(3). The majority of the body's melatonin is in the gastrointestinal system, and its release is not triggered by light and darkness but by the food we eat. I strongly suspect that this patient's constipation was triggered by his melatonin use. To date, this side effect has not been described in the medical literature. I suspect that this side effect may be due to melatonin's ability to increase colonic transit time(4). I have been remiss until now in reporting this side effect (as are many of my colleagues when it comes to reporting adverse effects of supplements purchased at health food stores), so I thank the CMAJ for giving mean opportunity to help raise awareness of this potential side effect.

    Melatonin is a fascinating chemical. Its sedative, analgesic, hypnotic, anticonvulsant, antioxidant, anti-inflammatory, immunomodulatory and chronobiotic properties raise hopes for numerous therapeutic possibilities. I hope that someday the CMAJ will do a more thorough literature review on the subject.

    Harold Pupko M.D.

    1)http://www.ncbi.nlm.nih.gov/pubmed/8365512

    2) http://www.ncbi.nlm.nih.gov/pubmed/22271210

    3) http://www.jpp.krakow.pl/journal/archive/08_08_s2/pdf/33_08_08_s2_article.pdf

    4) http://www.ncbi.nlm.nih.gov/pubmed/1872000

    Conflict of Interest:

    None declared

    Show Less
    Competing Interests: None declared.
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 184 (17)
CMAJ
Vol. 184, Issue 17
20 Nov 2012
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Melatonin
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Melatonin
Michael D. Carter, David N. Juurlink
CMAJ Nov 2012, 184 (17) 1923; DOI: 10.1503/cmaj.111765

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Melatonin
Michael D. Carter, David N. Juurlink
CMAJ Nov 2012, 184 (17) 1923; DOI: 10.1503/cmaj.111765
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Melatonin regulates the body’s sleep cycle
    • Melatonin is effective against jet lag
    • Melatonin may improve sleep
    • Melatonin is not a dietary supplement
    • Short-term use appears safe
    • Footnotes
    • References
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Azathioprine-induced severe anemia potentiated by the concurrent use of allopurinol
  • Schwannoma of the tongue
  • “Superscan” in diffusion-weighted imaging with background body suppression magnetic resonance imaging
Show more Practice

Similar Articles

Collections

  • Sections
    • Five Things to Know About
  • Topics
    • Sleep medicine

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire